Anamorelin Efficacy in Non–Small‐Cell Lung Cancer Patients With Cachexia: Insights From ROMANA 1 and ROMANA 2
ABSTRACT Background Cancer cachexia presents a significant challenge, but the ghrelin agonist anamorelin shows promise as a potential treatment. This study examined whether the baseline systemic inflammatory response (SIR) (measured by the modified Glasgow Prognostic Score [mGPS]), low BMI or greate...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2025-02-01
|
| Reeks: | Journal of Cachexia, Sarcopenia and Muscle |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/jcsm.13732 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|